HealthQuest Capital Closes on $440 Million Fund to Invest in Growth-Stage Companies Optimizing Value in Healthcare

HealthQuest Capital, a growth capital firm investing in companies that optimize value in healthcare, today announced the close of HealthQuest Partners III, L.P. at $440 million, oversubscribed and closed at the hard cap. Fund III will be invested in commercial-stage companies delivering innovation across all sectors of the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs.

Read More
Randy Scott
Avedro Announces Pricing of Initial Public Offering

HealthQuest portfolio company Avedro, Inc. (Nasdaq: AVDR), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $14.00 per share, for total gross proceeds of $70.0 million.

Read More
Randy Scott
Venus Heal™ Receives FDA Clearance

Venus Concept announces the launch of its latest device, Venus Heal, which is now cleared in the U.S. to treat soft tissue injuries and conditions. Venus Heal is intended to relieve pain, improve blood circulation, and increase range of motion through the relief of muscle spasm.

Read More
Randy Scott
Trice Medical Acquires SegWAY Orthopaedics

Trice Medical announced that it is acquiring S.E.GWAY Orthopaedics (SegWAY), a leader in solutions for minimally invasive orthopedic procedures. SegWAY is best known for its Endoscopic Carpal Tunnel Release (ECTR), a device that supports minimally invasive carpal tunnel surgeries.

Read More
Randy Scott
HealthQuest Co-Leads Investment into Etairos

HealthQuest has made an equity investment in Etairos Health. Etairos an in-home senior care company providing non-skilled and skilled care primarily to the senior population. Etairos acquires selected home care agencies that fit well with its care philosophy and business model, integrates and then expands them, allowing for the creation of a leading regional home care provider. 

Read More
Randy Scott
Biotheranostics’ Breast Cancer Index® Recently Recognized in Two National Clinical Practice Guidelines

Clinical Practice Guidelines Recognize Breast Cancer Index Clinical Utility Spans the Treatment Continuum for Patients with Early-Stage Estrogen Receptor Positive (ER+) Disease

Breast Cancer Index Endorsed in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Breast Cancer and American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Focused Update

Read More
Randy Scott